Evidence map›Paper›PMID 35905415›Full record

ArticleClinical and translational gastroenterology2022

Magnetic Resonance Enterography and Histology in Patients With Fibrostenotic Crohn's Disease: A Multicenter Study.

Alexandre Coimbra, Jordi Rimola, Miriam Cuatrecasas, Gert De Hertogh, Gert Van Assche, Ragna Vanslembrouck, Henning Glerup, Agnete Hedemann Nielsen, Rikke Hagemann-Madsen, Yoram Bouhnik and 14 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Clinical and translational gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Crohn Disease Strictures: Multimodality Imaging to Identify Imaging Biomarkers.Radiographics : a review publication of the Radiological Society of North America, Inc · 2025
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. The Diagnosis of Intestinal Fibrosis in Crohn's Disease-Present and Future.International journal of molecular sciences · 2024
    Review
  12. Imaging of Strictures in Crohn's Disease.Life (Basel, Switzerland) · 2023
    Review
  13. How to Evaluate Fibrosis in IBD?Diagnostics (Basel, Switzerland) · 2023
    Review
  14. Review
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 7 institutions in 6 countries.

Alexandre CoimbraEarly Clinical Development, Genentech, Inc., South San Francisco, California.ORCID 0000-0002-2037-8110
Jordi RimolaHospital Clinic, University of Barcelona, Barcelona, Spain.
Miriam CuatrecasasHospital Clinic, University of Barcelona, Barcelona, Spain.
Gert De HertoghUniversity Hospitals Leuven and University of Leuven, Belgium.
Gert Van AsscheUniversity Hospitals Leuven and University of Leuven, Belgium.
Ragna VanslembrouckUniversity Hospitals Leuven and University of Leuven, Belgium.
Henning GlerupSilkeborg Hospital, Silkeborg, Denmark; Lillebaelt Hospital, Vejle, Denmark.
Agnete Hedemann NielsenSilkeborg Hospital, Silkeborg, Denmark; Lillebaelt Hospital, Vejle, Denmark.
Rikke Hagemann-MadsenSilkeborg Hospital, Silkeborg, Denmark; Lillebaelt Hospital, Vejle, Denmark.
Yoram BouhnikHôpital Beaujon, Paris, France.
Magaly ZappaHôpital Beaujon, Paris, France.
Dominique Cazals-HatemHôpital Beaujon, Paris, France.
Geert D'HaensAmsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.
Jaap StokerAmsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.
Sybren MeijerAmsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.
Gerhard RoglerDepartment of Gastroenterology and Hepatology, University Hospital of Zurich and University of Zurich, Zurich, Switzerland.
Andreas BossInstitute of Diagnostic and Interventional Radiology, University Hospital of Zurich and University of Zurich, Zurich, Switzerland.
Achim WeberDepartment of Pathology and Molecular Pathology, University Hospital of Zurich and University of Zurich, Zurich, Switzerland.
Rui ZhaoEarly Clinical Development, Genentech, Inc., South San Francisco, California.
Mary E KeirEarly Clinical Development, Genentech, Inc., South San Francisco, California.
Alexis ScherlEarly Clinical Development, Genentech, Inc., South San Francisco, California.
Alex de CrespignyEarly Clinical Development, Genentech, Inc., South San Francisco, California.
Timothy T LuEarly Clinical Development, Genentech, Inc., South San Francisco, California.
Julián PanésHospital Clinic, University of Barcelona, Barcelona, Spain.
Amsterdam University Medical Centers · NLHôpital Beaujon · FRKU Leuven · BERegionshospitalet Silkeborg · DKUniversitat de Barcelona · ESUniversity of Zurich · CHUniversity Hospital of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMagnetic resonance enterography (MRE) is useful for detecting bowel strictures, whereas a number of imaging biomarkers may reflect severity of fibrosis burden in Crohn's disease (CD). This study aimed to verify the association of MRE metrics with histologic fibrosis independent of inflammation.

methodsThis prospective European multicenter study performed MRE imaging on 60 patients with CD with bowel strictures before surgical resection. Locations of 61 histological samples were annotated on MRE examinations, followed by central readings using the Chiorean score and measurement of delayed gain of enhancement (DGE), magnetization transfer ratio, T2-weighted MRI sequences (T2R), apparent diffusion coefficient (ADC), and the magnetic resonance index of activity (MaRIA). Correlations of histology and MRE metrics were assessed. Least Absolute Shrinkage and Selection Operator and receiver operator characteristic (ROC) curve analyses were used to select composite MRE scores predictive of histology and to estimate their predictive value.

resultsADC and MaRIA correlated with fibrosis (R = -0.71, P < 0.0001, and 0.59, P < 0.001) and more moderately with inflammation (R = -0.35, P < 0.01, and R = 0.53, P < 0.001). Lower or no correlations of fibrosis or inflammation were found with DGE, magnetization transfer ratio, or T2R. Least Absolute Shrinkage and Selection Operator and ROC identified a composite score of MaRIA, ADC, and DGE as a very good predictor of histologic fibrosis (ROC area under the curve = 0.910). MaRIA alone was the best predictor of histologic inflammation with excellent performance in identifying active histologic inflammation (ROC area under the curve = 0.966). DISCUSSION: MRE-based scores for histologic fibrosis and inflammation may assist in the characterization of CD stenosis and enable development of fibrosis-targeted therapies and clinical treatment of stenotic patients.

Indexed as

Crohn DiseaseConstriction, PathologicFibrosisHumansInflammationMagnetic Resonance ImagingMagnetic Resonance SpectroscopyProspective Studies

Identifiers

PMID35905415
PMCPMC10476777
OpenAlexW4282598481

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.